15 What’s more, it is also illustrated that YLT−11 (PLK4 inhibitor) suppresses breast cancer growth in xenograft models.7 In the current study, PLK4 inhibitor exhibited a capability in decreasing ATC cell viability, while promoting cell apoptosis. The gene discussed is PLK4; the disease is breast carcinoma.